Our research focuses on treatment for patients who have experienced multiple traumas, most often beginning with abuse in childhood, and who suffer from a wide array of post-traumatic symptoms in adult life.
For many years, we have been collecting initial and follow-up data
from patients in treatment at the Victims of Violence Program (VOV),
tracking their progress in a naturalistic study of treatment outcome.
Patients have routinely been asked to complete a packet of self-report
measures. In addition, a small sub-group of patients have volunteered to
be interviewed for a measure of resilience and recovery developed by
our founding program director, Mary Harvey, Ph.D. Over the years, this
data set has been the basis for numerous articles and book chapters (see PUBLICATIONS).
With support from the Annenberg Foundation, we have also recently
completed a treatment manual, based on a model of time-limited group
psychotherapy that has been practiced at VoV for many years. This
manual has just been published as a book: The Trauma Recovery Group, by
Guilford Press (see PUBLICATIONS).
The VOV is currently involved in a large-scale randomized controlled trial of an evidence-based treatment of PTSD, funded by the National Institute of Mental Health. VOV is one of several sites nationally engaged this trial, which compares a new cognitive-behavioral treatment model for women with histories of interpersonal violence with the established treatment practices at the participating public-sector mental health clinics.
The VOV research team also traditionally includes our post-doctoral fellows. Other VOV trainees are welcome but not required to participate. We expect our fellows to identify their own projects, based either on the VOV data set or on another related source of data. We encourage our fellows to present their original ideas as posters within the Harvard Department of Psychiatry, as conference papers, and as articles in professional journals. In this way, we hope to prepare the next generation to make their own original contributions to progress in the treatment of patients with complex trauma.